D&A at other companies
Other financials
Where this comes from
Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Depreciation.
The official record: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Maravai LifeSciences Holdings, Inc.'s d&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Maravai LifeSciences Holdings, Inc.'s D&A?
- Maravai LifeSciences Holdings, Inc. (MRVI) reported D&A of $4.9M in Q1 2026.
- How has Maravai LifeSciences Holdings, Inc.'s D&A changed year-over-year?
- Maravai LifeSciences Holdings, Inc.'s D&A decreased by 13.9% year-over-year, from $5.69M to $4.9M.
- What is the long-term trend for Maravai LifeSciences Holdings, Inc.'s D&A?
- Over 4 years (2021 to 2025), Maravai LifeSciences Holdings, Inc.'s D&A has grown at a 38.4% compound annual growth rate (CAGR), from $6.41M to $23.56M.
- What does D&A mean?
- Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.